OC.06.7 LOWER INCIDENCE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH NON-GUT SELECTIVE BIOLOGIC THERAPY

MLA

M.C. Monico, et al. “Oc.06.7 Lower Incidence of Covid-19 in Patients with Inflammatory Bowel Disease Treated with Non-Gut Selective Biologic Therapy.” Digestive and Liver Disease, vol. 53, Sept. 2021, pp. S117–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec1e735ebe6e7dccf97e1c3aa9c4fc67&authtype=sso&custid=ns315887.

APA

M.C. Monico, Rosanna Cannatelli, A.M. Carvalhas Gabrielli, Stefania Carmagnola, Giovanni Maconi, Sandro Ardizzone, & Francesca Ferretti. (2021). Oc.06.7 Lower Incidence of Covid-19 in Patients with Inflammatory Bowel Disease Treated with Non-Gut Selective Biologic Therapy. Digestive and Liver Disease, 53, S117–S118.

Chicago

M.C. Monico, Rosanna Cannatelli, A.M. Carvalhas Gabrielli, Stefania Carmagnola, Giovanni Maconi, Sandro Ardizzone, and Francesca Ferretti. 2021. “Oc.06.7 Lower Incidence of Covid-19 in Patients with Inflammatory Bowel Disease Treated with Non-Gut Selective Biologic Therapy.” Digestive and Liver Disease 53 (September): S117–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ec1e735ebe6e7dccf97e1c3aa9c4fc67&authtype=sso&custid=ns315887.